Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03580655
Brief Title: (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

First Submitted : May 3, 2018
First Submitted that Met QC Criteria : June 26, 2018
First Posted : July 9, 2018

Last Update Submitted that Met QC Criteria : December 18, 2020
Last Update Posted : December 21, 2020